dansylsarcosine has been researched along with 1,6-bismaleimidohexane in 1 studies
| Studies (dansylsarcosine) | Trials (dansylsarcosine) | Recent Studies (post-2010) (dansylsarcosine) | Studies (1,6-bismaleimidohexane) | Trials (1,6-bismaleimidohexane) | Recent Studies (post-2010) (1,6-bismaleimidohexane) |
|---|---|---|---|---|---|
| 40 | 1 | 5 | 36 | 0 | 5 |
| Protein | Taxonomy | dansylsarcosine (IC50) | 1,6-bismaleimidohexane (IC50) |
|---|---|---|---|
| G-protein coupled receptor 35 isoform a | Homo sapiens (human) | 6.2319 | |
| G-protein coupled receptor 55 | Homo sapiens (human) | 9.7907 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 4.94 | |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | Mycobacterium tuberculosis H37Rv | 118.32 | |
| Monoglyceride lipase | Homo sapiens (human) | 1.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anraku, M; Chuang, VT; Kawai, K; Komatsu, T; Maruyama, T; Otagiri, M; Seo, H; Taguchi, K; Tanaka, R; Urata, Y; Yamasaki, K | 1 |
1 other study(ies) available for dansylsarcosine and 1,6-bismaleimidohexane
| Article | Year |
|---|---|
Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs.
Topics: Animals; Binding Sites; Dansyl Compounds; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dimerization; Drug Carriers; Fatty Acids; Fluorescent Dyes; Half-Life; Humans; Hypoglycemic Agents; Male; Maleimides; Permeability; Plasma; Protein Binding; Rats; Rats, Sprague-Dawley; Sarcosine; Serum Albumin; Warfarin | 2015 |